lc16m8
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2004 (NCT00103584)
Timeline
Indications
Mechanism of action
- OrthopoxvirusImmunity, active
Orthopoxvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lc16m8
- lc16m8
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06223919 | Phase 3 | Dec 16, 2023 | Government of Colombia, Government of Japan, Japan Agency for Medical Research and Development, National Center for Global Health and Medicine, Universidad Nacional de Colombia |
| NCT00103584 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2004 | VaxGen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Colombia | Government | 1 | 0 | 1 | 2023 |
| Government of Japan | Government | 1 | 0 | 1 | 2023 |
| Japan Agency for Medical Research and Development | Government | 1 | 0 | 1 | 2023 |
| National Center for Global Health and Medicine | Government | 1 | 0 | 1 | 2023 |
| Universidad Nacional de Colombia | Academic/Hospital | 1 | 1 | 1 | 2023 |
| VaxGen | For profit | 1 | 1 | 1 | 2004 |
6 organizations
Page 1 / 1